Literature DB >> 27819471

Validating dimensions of psychosis symptomatology: Neural correlates and 20-year outcomes.

Roman Kotov1, Dan Foti2, Kaiqiao Li3, Evelyn J Bromet3, Greg Hajcak3, Camilo J Ruggero4.   

Abstract

Heterogeneity of psychosis presents significant challenges for classification. Between 2 and 12 symptom dimensions have been proposed, and consensus is lacking. The present study sought to identify uniquely informative models by comparing the validity of these alternatives. An epidemiologic cohort of 628 first-admission inpatients with psychosis was interviewed 6 times over 2 decades and completed an electrophysiological assessment of error processing at year 20. We first analyzed a comprehensive set of 49 symptoms rated by interviewers at baseline, progressively extracting from 1 to 12 factors. Next, we compared the ability of resulting factor solutions to (a) account for concurrent neural dysfunction and (b) predict 20-year role, social, residential, and global functioning, and life satisfaction. A four-factor model showed incremental validity with all outcomes, and more complex models did not improve explanatory power. The 4 dimensions-reality distortion, disorganization, inexpressivity, and apathy/asociality-were replicable in 5 follow-ups, internally consistent, stable across assessments, and showed strong discriminant validity. These results reaffirm the value of separating disorganization and reality distortion, are consistent with recent findings distinguishing inexpressivity and apathy/asociality, and suggest that these 4 dimensions are fundamental to understanding neural abnormalities and long-term outcomes in psychosis. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27819471      PMCID: PMC5119925          DOI: 10.1037/abn0000188

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  92 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 2.  Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.

Authors:  Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; Rajiv Tandon; Ming Tsuang; Jim Van Os; William Carpenter
Journal:  Schizophr Res       Date:  2013-05-22       Impact factor: 4.939

Review 3.  Subtyping schizophrenia: implications for genetic research.

Authors:  A Jablensky
Journal:  Mol Psychiatry       Date:  2006-06-27       Impact factor: 15.992

Review 4.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

5.  Modeling psychopathology structure: a symptom-level analysis of Axis I and II disorders.

Authors:  K E Markon
Journal:  Psychol Med       Date:  2009-06-11       Impact factor: 7.723

6.  Hierarchical organization of axis I psychiatric disorder comorbidity through age 30.

Authors:  Richard F Farmer; John R Seeley; Derek B Kosty; Thomas M Olino; Peter M Lewinsohn
Journal:  Compr Psychiatry       Date:  2013-01-16       Impact factor: 3.735

7.  Illness insight and neurophysiological error-processing deficits in schizophrenia.

Authors:  Vinay Kansal; Iulia Patriciu; Michael Kiang
Journal:  Schizophr Res       Date:  2014-04-13       Impact factor: 4.939

8.  Thought disorder in the meta-structure of psychopathology.

Authors:  K M Keyes; N R Eaton; R F Krueger; A E Skodol; M M Wall; B Grant; L J Siever; D S Hasin
Journal:  Psychol Med       Date:  2012-11-21       Impact factor: 7.723

9.  Boundaries of schizoaffective disorder: revisiting Kraepelin.

Authors:  Roman Kotov; Shirley H Leong; Ramin Mojtabai; Ann C Eckardt Erlanger; Laura J Fochtmann; Eduardo Constantino; Gabrielle A Carlson; Evelyn J Bromet
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

10.  Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Authors:  Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

View more
  23 in total

1.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

2.  Transdiagnostic neural markers of emotion-cognition interaction in psychotic disorders.

Authors:  Amri Sabharwal; Akos Szekely; Roman Kotov; Prerona Mukherjee; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2016-09-12

3.  Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood.

Authors:  Katherine Jonas; Sean Clouston; Kaiqiao Li; Laura J Fochtmann; Todd Lencz; Anil K Malhotra; David Cicero; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  Schizophr Res       Date:  2018-12-21       Impact factor: 4.939

4.  Symptom-level analysis of DSM-IV/DSM-5 personality pathology in later life: Hierarchical structure and predictive validity across self- and informant ratings.

Authors:  Michael J Boudreaux; Susan C South; Thomas F Oltmanns
Journal:  J Abnorm Psychol       Date:  2019-07

5.  Toward a Neural Model of the Openness-Psychoticism Dimension: Functional Connectivity in the Default and Frontoparietal Control Networks.

Authors:  Scott D Blain; Rachael G Grazioplene; Yizhou Ma; Colin G DeYoung
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

6.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

7.  Neural markers of emotional face perception across psychotic disorders and general population.

Authors:  Amri Sabharwal; Roman Kotov; Akos Szekely; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2017-05-29

8.  A detailed hierarchical model of psychopathology: From individual symptoms up to the general factor of psychopathology.

Authors:  Miriam K Forbes; Matthew Sunderland; Ronald M Rapee; Philip J Batterham; Alison L Calear; Natacha Carragher; Camilo Ruggero; Mark Zimmerman; Andrew J Baillie; Samantha J Lynch; Louise Mewton; Tim Slade; Robert F Krueger
Journal:  Clin Psychol Sci       Date:  2021-02-19

9.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

10.  An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.

Authors:  Dominic B Dwyer; Janos L Kalman; Monika Budde; Joseph Kambeitz; Anne Ruef; Linda A Antonucci; Lana Kambeitz-Ilankovic; Alkomiet Hasan; Ivan Kondofersky; Heike Anderson-Schmidt; Katrin Gade; Daniela Reich-Erkelenz; Kristina Adorjan; Fanny Senner; Sabrina Schaupp; Till F M Andlauer; Ashley L Comes; Eva C Schulte; Farah Klöhn-Saghatolislam; Anna Gryaznova; Maria Hake; Kim Bartholdi; Laura Flatau-Nagel; Markus Reitt; Silke Quast; Sophia Stegmaier; Milena Meyers; Barbara Emons; Ida Sybille Haußleiter; Georg Juckel; Vanessa Nieratschker; Udo Dannlowski; Tomoya Yoshida; Max Schmauß; Jörg Zimmermann; Jens Reimer; Jens Wiltfang; Eva Reininghaus; Ion-George Anghelescu; Volker Arolt; Bernhard T Baune; Carsten Konrad; Andreas Thiel; Andreas J Fallgatter; Christian Figge; Martin von Hagen; Manfred Koller; Fabian U Lang; Moritz E Wigand; Thomas Becker; Markus Jäger; Detlef E Dietrich; Harald Scherk; Carsten Spitzer; Here Folkerts; Stephanie H Witt; Franziska Degenhardt; Andreas J Forstner; Marcella Rietschel; Markus M Nöthen; Nikola Mueller; Sergi Papiol; Urs Heilbronner; Peter Falkai; Thomas G Schulze; Nikolaos Koutsouleris
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.